Department of Ophthalmology, SUNY Upstate Medical University, Syracuse, New York 13210, USA.
Ophthalmic Plast Reconstr Surg. 2009 Nov-Dec;25(6):437-9. doi: 10.1097/IOP.0b013e3181b80d63.
To report the first accurate prevalence of canaliculitis associated with the use of the SmartPlug.
All patients from a single private ophthalmology practice who received SmartPlugs from 2002 to 2007 were identified. All patients from the private ophthalmology practice that developed canaliculitis secondary to SmartPlug insertion were referred to a single private ophthalmic plastic and reconstructive surgery office. A retrospective review of those 17 patients was performed.
From 2002 to 2007, a total of 235 patients were identified from a single private ophthalmology practice with a total of 402 SmartPlugs inserted. Of those 235 patients, 17 developed canaliculitis and were referred to a single private ophthalmic plastic and reconstructive surgery office. The prevalence of canaliculitis per patient was 7.23%. The prevalence of canaliculitis per SmartPlug inserted was 4.73%. The average time from SmartPlugs insertion to onset of symptoms was 3 years. All affected patients required canaliculotomy and plug removal.
This is the first study reporting the prevalence of canaliculitis associated with the use of the SmartPlug. All affected patients required surgical intervention, after which many continued to have dry eye and one required bilateral Jones tubes. Ophthalmologists using the SmartPlug for the treatment of dry eye syndrome should carefully weigh the risks and benefits of their use.
报告首例与 SmartPlug 使用相关的泪小管炎的准确患病率。
从 2002 年至 2007 年在一家私人眼科诊所使用 SmartPlug 的所有患者均被确定。所有因 SmartPlug 插入而继发泪小管炎的患者均被转诊至一家私人眼科整形和重建手术办公室。对这 17 名患者进行回顾性分析。
从 2002 年至 2007 年，从一家私人眼科诊所共确定了 235 名患者，总共插入了 402 个 SmartPlug。在这 235 名患者中，有 17 名发生了泪小管炎，并被转诊至一家私人眼科整形和重建手术办公室。每位患者的泪小管炎患病率为 7.23%。每个插入的 SmartPlug 的泪小管炎患病率为 4.73%。从 SmartPlug 插入到症状出现的平均时间为 3 年。所有受影响的患者均需要进行泪小管切开术和拔出塞子。
这是第一项报告与 SmartPlug 使用相关的泪小管炎患病率的研究。所有受影响的患者均需要手术干预，此后许多患者仍存在干眼，有 1 例需要双侧 Jones 管。使用 SmartPlug 治疗干眼症的眼科医生应仔细权衡其使用的风险和收益。
